Division of General Internal Medicine (Fralick, Goldberg, Rohailla, Razak, Verma) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Guo), St. Michael's Hospital, Toronto, Ont.; Department of Neurology (Burke), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.; Division of General Internal Medicine (Lapointe-Shaw, Rawal), University Health Network; Department of Medicine (Lapointe-Shaw, Rawal), University of Toronto; Division of General Internal Medicine (Kwan), Mount Sinai Hospital; Division of General Internal Medicine (Weinerman), Sunnybrook Health Sciences Centre, Toronto, Ont.; Program of Medicine and Institute for Better Health (Tang), Trillium Health Partners, Mississauga, Ont.
CMAJ. 2019 Aug 6;191(31):E853-E859. doi: 10.1503/cmaj.190111.
Transthoracic echocardiography is routinely performed in patients with stroke or transient ischemic attack (TIA) to help plan secondary stroke management, but recent data evaluating its usefulness in this context are lacking. We sought to evaluate the value of echocardiography for identifying clinically actionable findings for secondary stroke prevention.
We conducted a multicentre cohort study of patients admitted to hospital with stroke or TIA between 2010 and 2015 at 2 academic hospitals in Toronto, Ontario, Canada. Clinically actionable echocardiographic findings for secondary stroke prevention included cardiac thrombus, patent foramen ovale, atrial myxoma or valvular vegetation. We identified patient characteristics associated with clinically actionable findings using logistic regression.
Of the 1862 patients with stroke or TIA we identified, 1272 (68%) had at least 1 echocardiogram. Nearly all echocardiograms were transthoracic; 1097 (86%) were normal, 1 (0.08%) had an atrial myxoma, 2 (0.2%) had a valvular vegetation, 11 (0.9%) had a cardiac thrombus and 66 (5.2%) had a PFO. Patent foramen ovale was less likely among patients older than 60 years (adjusted odds ratio [OR] 0.34, 95% confidence interval [CI] 0.20-0.57), with prior stroke or TIA (adjusted OR 0.31, 95% CI 0.09-0.76) or with dyslipidemia (adjusted OR 0.39, 95% CI 0.15-0.84). Among the 130 patients with cryptogenic stroke who had an echocardiogram ( = 110), a PFO was detected in 19 (17%) on transthoracic echocardiogram.
Most patients with stroke or TIA had a normal echocardiogram, with few having clinically actionable findings for secondary stroke prevention. Clinically actionable findings, specifically PFO, were more common in patients with cryptogenic stroke.
经胸超声心动图常用于诊断中风或短暂性脑缺血发作(TIA)患者,以帮助规划二级中风管理,但目前缺乏评估其在该环境下应用价值的相关数据。我们旨在评估超声心动图在识别二级中风预防中具有临床意义的发现的价值。
我们在加拿大安大略省多伦多的 2 家学术医院开展了一项多中心队列研究,纳入了 2010 年至 2015 年间因中风或 TIA 住院的患者。二级中风预防中具有临床意义的超声心动图发现包括心内血栓、卵圆孔未闭、心房黏液瘤或瓣膜赘生物。我们使用逻辑回归识别与具有临床意义的发现相关的患者特征。
在我们确定的 1862 例中风或 TIA 患者中,有 1272 例(68%)至少进行了 1 次超声心动图检查。几乎所有的超声心动图均为经胸超声心动图;1097 例(86%)正常,1 例(0.08%)患有心房黏液瘤,2 例(0.2%)患有瓣膜赘生物,11 例(0.9%)患有心内血栓,66 例(5.2%)患有卵圆孔未闭。60 岁以上的患者卵圆孔未闭的可能性较小(校正比值比 [OR] 0.34,95%置信区间 [CI] 0.20-0.57),有既往中风或 TIA(校正 OR 0.31,95% CI 0.09-0.76)或血脂异常(校正 OR 0.39,95% CI 0.15-0.84)的患者也更有可能出现这种情况。在 130 例经超声心动图诊断为隐源性中风的患者中( = 110),19 例(17%)经经胸超声心动图检测到卵圆孔未闭。
大多数中风或 TIA 患者的超声心动图正常,很少有二级中风预防的具有临床意义的发现。具体而言,卵圆孔未闭在隐源性中风患者中更为常见。